South Korea Interventional Cardiology Devices Market Size, Share, Trends and Forecast by Product, End User, and Region, 2026-2034
The South Korea interventional cardiology devices market size reached USD 497.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 852.7 Million by 2034, exhibiting a growth rate (CAGR) of 5.99% during 2026-2034. South Korea is experiencing a rise in cardiovascular diseases like coronary heart disease, stroke, and hypertension. Moreover, dramatic shift towards minimally invasive cardiac interventions, led primarily by developments in device miniaturization, flexibility, and material make-up is supporting the market growth. Additionally, the improved healthcare infrastructure and proactive government support are expanding the South Korea interventional cardiology devices market share.
SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET TRENDS:
Increasing Incidence of Cardiovascular Disease and Aging Population
South Korea is also experiencing a rise in cardiovascular diseases like coronary heart disease, stroke, and hypertension. All these are mostly caused by lifestyle changes like high intakes of processed foods, lack of physical activity, smoking, and stress. To add to this, the nation's fast-growing aging population is exacerbating the problem, as the elderly are more likely to be affected by heart ailments. According to recent statistics from the Ministry of the Interior and Safety, the population of individuals aged 65 and above is 10.24 million, representing 20% of South Korea's total population of 51 million. Therefore, the need for interventional cardiology interventions like angioplasty and stenting rising among the geriatric population. These treatments are almost entirely dependent on devices like balloon catheters, guidewires, and drug-eluting stents. Hospitals and clinics are increasingly spending money on these technologies to meet the mounting patient load. As such, the patient base and related requirement for efficient, non-invasive forms of treatment are taking center stage in propelling the South Korea interventional cardiology devices market growth.
Technological Advancements and Shift Toward Minimally Invasive Procedures
Technological improvement is a key driver revolutionizing interventional cardiology in South Korea. There has been a dramatic shift towards minimally invasive cardiac interventions, led primarily by developments in device miniaturization, flexibility, and material make-up. More advanced-generation stents, image-guided catheters, and pressure-sensing guidewires are enhancing the accuracy and success rate of interventions. Such technologies are allowing cardiologists to treat complex lesions with increased safety, reduced procedure time, and faster patient recovery. Minimally invasive procedures are also becoming popular among patients because of shorter hospital stays, minimal post-operative pain, and lower rates of complications. Hospitals and specialty clinics are now more commonly provided with sophisticated laboratories and hybrid operating rooms to support such procedures. As competition between manufacturers increases, product development is becoming quicker, with companies introducing next-generation drug-eluting stents, bioresorbable scaffolds, and imaging devices. This incessant flow of technological advancements is not only broadening the horizons of interventional cardiology but also speeding up its implementation in South Korea's healthcare centers. In 2025, Siemens Healthineers Korea has entered a strategic memorandum of understanding (MOU) with Phantomics, a Korean expert in cardiac imaging AI, to collaboratively promote the clinical implementation of AI-driven cardiac MRI analysis.
Government Support, Sophisticated Healthcare Infrastructure, and Insurance Coverage
South Korea's strong healthcare infrastructure and proactive government support are positively influencing the market. The nation has invested heavily in enhancing its healthcare system, with a focus on specialized cardiology care units and integration of medical technology. Government programs of early diagnosis and preventive cardiology are facilitating the identification of patients earlier in the course of the disease, resulting in increased numbers of interventional procedures. Moreover, positive reimbursement policies and universal healthcare coverage have lowered out-of-pocket costs for patients receiving interventional procedures. This has made them more accessible and affordable, prompting more individuals to choose advanced cardiac interventions. The regulatory climate in South Korea is also conducive to medical device development, facilitating quicker approval and implementation of new technology. In addition, an abundance of skilled interventional cardiologists and ongoing programs for medical training provide assurance that the healthcare workforce is equipped to utilize the most advanced devices.
SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product and end user.
Product Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea interventional cardiology devices market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea interventional cardiology devices market on the basis of product?
What is the breakup of the South Korea interventional cardiology devices market on the basis of end user?
What is the breakup of the South Korea interventional cardiology devices market on the basis of region?
What are the various stages in the value chain of the South Korea interventional cardiology devices market?
What are the key driving factors and challenges in the South Korea interventional cardiology devices market?
What is the structure of the South Korea interventional cardiology devices market and who are the key players?
What is the degree of competition in the South Korea interventional cardiology devices market?
SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET TRENDS:
Increasing Incidence of Cardiovascular Disease and Aging Population
South Korea is also experiencing a rise in cardiovascular diseases like coronary heart disease, stroke, and hypertension. All these are mostly caused by lifestyle changes like high intakes of processed foods, lack of physical activity, smoking, and stress. To add to this, the nation's fast-growing aging population is exacerbating the problem, as the elderly are more likely to be affected by heart ailments. According to recent statistics from the Ministry of the Interior and Safety, the population of individuals aged 65 and above is 10.24 million, representing 20% of South Korea's total population of 51 million. Therefore, the need for interventional cardiology interventions like angioplasty and stenting rising among the geriatric population. These treatments are almost entirely dependent on devices like balloon catheters, guidewires, and drug-eluting stents. Hospitals and clinics are increasingly spending money on these technologies to meet the mounting patient load. As such, the patient base and related requirement for efficient, non-invasive forms of treatment are taking center stage in propelling the South Korea interventional cardiology devices market growth.
Technological Advancements and Shift Toward Minimally Invasive Procedures
Technological improvement is a key driver revolutionizing interventional cardiology in South Korea. There has been a dramatic shift towards minimally invasive cardiac interventions, led primarily by developments in device miniaturization, flexibility, and material make-up. More advanced-generation stents, image-guided catheters, and pressure-sensing guidewires are enhancing the accuracy and success rate of interventions. Such technologies are allowing cardiologists to treat complex lesions with increased safety, reduced procedure time, and faster patient recovery. Minimally invasive procedures are also becoming popular among patients because of shorter hospital stays, minimal post-operative pain, and lower rates of complications. Hospitals and specialty clinics are now more commonly provided with sophisticated laboratories and hybrid operating rooms to support such procedures. As competition between manufacturers increases, product development is becoming quicker, with companies introducing next-generation drug-eluting stents, bioresorbable scaffolds, and imaging devices. This incessant flow of technological advancements is not only broadening the horizons of interventional cardiology but also speeding up its implementation in South Korea's healthcare centers. In 2025, Siemens Healthineers Korea has entered a strategic memorandum of understanding (MOU) with Phantomics, a Korean expert in cardiac imaging AI, to collaboratively promote the clinical implementation of AI-driven cardiac MRI analysis.
Government Support, Sophisticated Healthcare Infrastructure, and Insurance Coverage
South Korea's strong healthcare infrastructure and proactive government support are positively influencing the market. The nation has invested heavily in enhancing its healthcare system, with a focus on specialized cardiology care units and integration of medical technology. Government programs of early diagnosis and preventive cardiology are facilitating the identification of patients earlier in the course of the disease, resulting in increased numbers of interventional procedures. Moreover, positive reimbursement policies and universal healthcare coverage have lowered out-of-pocket costs for patients receiving interventional procedures. This has made them more accessible and affordable, prompting more individuals to choose advanced cardiac interventions. The regulatory climate in South Korea is also conducive to medical device development, facilitating quicker approval and implementation of new technology. In addition, an abundance of skilled interventional cardiologists and ongoing programs for medical training provide assurance that the healthcare workforce is equipped to utilize the most advanced devices.
SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product and end user.
Product Insights:
- Stents
- Drug Eluting Stents
- Bare Metal Stents
- Bio-Absorbable Stents
- Interventional Catheters
- IVUS Catheters
- Guiding Catheters
- Angiography Catheters
- PTCA Guidewires
- Balloon Inflation Device
- PTCA Balloons
- Cutting Balloons
- Scoring Balloons
- Drug Eluting Balloons
- Normal Balloons
End User Insights:
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea interventional cardiology devices market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea interventional cardiology devices market on the basis of product?
What is the breakup of the South Korea interventional cardiology devices market on the basis of end user?
What is the breakup of the South Korea interventional cardiology devices market on the basis of region?
What are the various stages in the value chain of the South Korea interventional cardiology devices market?
What are the key driving factors and challenges in the South Korea interventional cardiology devices market?
What is the structure of the South Korea interventional cardiology devices market and who are the key players?
What is the degree of competition in the South Korea interventional cardiology devices market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - BREAKUP BY PRODUCT
6.1 Stents
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Drug Eluting Stents
6.1.3.2 Bare Metal Stents
6.1.3.3 Bio-Absorbable Stents
6.1.4 Market Forecast (2026-2034)
6.2 Interventional Catheters
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Segmentation
6.2.3.1 IVUS Catheters
6.2.3.2 Guiding Catheters
6.2.3.3 Angiography Catheters
6.2.4 Market Forecast (2026-2034)
6.3 PTCA Guidewires
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Balloon Inflation Device
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (2026-2034)
6.5 PTCA Balloons
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2020-2025)
6.5.3 Market Segmentation
6.5.3.1 Cutting Balloons
6.5.3.2 Scoring Balloons
6.5.3.3 Drug Eluting Balloons
6.5.3.4 Normal Balloons
6.5.4 Market Forecast (2026-2034)
7 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - BREAKUP BY END USER
7.1 Hospitals
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Ambulatory Surgical Centers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Others
7.3.1 Historical and Current Market Trends (2020-2025)
7.3.2 Market Forecast (2026-2034)
8 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET – BREAKUP BY REGION
8.1 Seoul Capital Area
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Product
8.1.4 Market Breakup by End User
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Yeongnam (Southeastern Region)
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Product
8.2.4 Market Breakup by End User
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Honam (Southwestern Region)
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Product
8.3.4 Market Breakup by End User
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Hoseo (Central Region)
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Product
8.4.4 Market Breakup by End User
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET – COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 PROFILES OF KEY PLAYERS
10.1 Company A
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - INDUSTRY ANALYSIS
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - BREAKUP BY PRODUCT
6.1 Stents
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Drug Eluting Stents
6.1.3.2 Bare Metal Stents
6.1.3.3 Bio-Absorbable Stents
6.1.4 Market Forecast (2026-2034)
6.2 Interventional Catheters
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Segmentation
6.2.3.1 IVUS Catheters
6.2.3.2 Guiding Catheters
6.2.3.3 Angiography Catheters
6.2.4 Market Forecast (2026-2034)
6.3 PTCA Guidewires
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Balloon Inflation Device
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (2026-2034)
6.5 PTCA Balloons
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2020-2025)
6.5.3 Market Segmentation
6.5.3.1 Cutting Balloons
6.5.3.2 Scoring Balloons
6.5.3.3 Drug Eluting Balloons
6.5.3.4 Normal Balloons
6.5.4 Market Forecast (2026-2034)
7 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - BREAKUP BY END USER
7.1 Hospitals
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Ambulatory Surgical Centers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Others
7.3.1 Historical and Current Market Trends (2020-2025)
7.3.2 Market Forecast (2026-2034)
8 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET – BREAKUP BY REGION
8.1 Seoul Capital Area
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Product
8.1.4 Market Breakup by End User
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Yeongnam (Southeastern Region)
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Product
8.2.4 Market Breakup by End User
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Honam (Southwestern Region)
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Product
8.3.4 Market Breakup by End User
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Hoseo (Central Region)
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Product
8.4.4 Market Breakup by End User
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET – COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 PROFILES OF KEY PLAYERS
10.1 Company A
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET - INDUSTRY ANALYSIS
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 APPENDIX
